References
1. Vetrovoy O.V., Rybnikova E.A., Samoylov M.O. Cerebral mechanisms of hypoxic/ischemic postconditioning. Biokhimiya [Biochemistry]. 2017; 82 (3): 392–400. DOI: https://doi.org/10.1134/S000629791703018X (in Russian)
2. Lee R.H.C., Lee M.H.H., Wu C.Y.C., Couto e Silva A., Possoit H.E., Hsieh T.H., et al. Cerebral ischemia and neuroregeneration. Neural Regen Res. 2018; 13 (3): 373–85. DOI: https://doi.org/10.4103/1673-5374.228711
3. Paolucci S., Iosa M., Coiro P., Venturiero V., Savo A., De Angelis D., et al. Post-stroke depression increases disability more than 15% in ischemic stroke survivors: a case-control study. Front Neurol. 2019; 10: 926. DOI: https://doi.org/10.3389/fneur.2019.00926
4. Voronina T.A. The role of hypoxia in stroke and convulsive states. Antihypoxants. Obzory po klinicheskoy farmakologii i lekarstvennoy terapii [Reviews on Clinical Pharmacology and Drug Therapy]. 2016; 14 (1): 63–79. DOI: https://doi.org/10.17816/RCF14163-70 (in Russian)
5. Latorre R., Sternini C., De Giorgio R., Greenwood-Van Meerveld B. Enteroendocrine cells: a review of their role in brain-gut communication. Neurogastroenterol Motil. 2016; 28 (5): 620–30. DOI: https://doi.org/10.1111/nmo.12754
6. Savignac H.M., Tramullas M., Kiely B., Dinan T.G. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res. 2015; 287: 59–72. DOI: https://doi.org/10.1016/j.bbr.2015.02.044
7. Savignac H.M., Kiely B., Dinan T.G., Cryan J.F. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil. 2014; 26 (11): 1615–27. DOI: https://doi.org/10.1111/nmo.12427
8. Bercik P., Park A.J., Sinclair D., Khoshdel A., Lu J., Huang X., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011; 23 (12): 1132–9. DOI: https://doi.org/10.1111/j.1365-2982.2011.01796.x
9. Arseneault-Bréard J., Rondeau I., Gilbert K., Girard Stéphanie-Anne, Tompkins T.A., Godbout R., et al. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br J Nutr. 2012; 107 (12): 1793–9. DOI: https://doi.org/10.1017/S0007114511005137
10. Battaglini D., Pimentel-Coelho P.M., Robba C., Dos Santos C.C., Cruz F.F., Pelosi P., et al. Gut microbiota in acute ischemic stroke: from pathophysiology to therapeutic implications. Front Neurol. 2020; 11: 598. DOI: https://doi.org/10.3389/fneur.2020.00598
11. Akhoundzadeh K., Vakili A., Shadnoush M., Sadeghzadeh J. Effects of the oral ingestion of probiotics on brain damage in a transient model of focal cerebral ischemia in mice. Iran J Med Sci. 2018; 43 (1): 32–40. PMCID: PMC5775992.
12. Rahmati H., Momenabadi S., Vafaei A.A., Bandegi A. R., Mazaheri Z., Vakili A. Probiotic supplementation attenuates hippocampus injury and spatial learning and memory impairments in a cerebral hypoperfusion mouse model. Mol Biol Rep. 2019; 46 (5): 4985–95. DOI: https://doi.org/10.1007/s11033-019-04949-7
13. Yamashiro K., Tanaka R., Urabe T., Ueno Y., Yamashiro Y., Nomoto K., et al. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One. 2017; 12 (2). DOI: https://doi.org/10.1371/journal.pone.0176062
14. Rice M.W., Pandya J.D., Shear D.A. Gut microbiota as a therapeutic target to ameliorate the biochemical, neuroanatomical, and behavioral effects of traumatic brain injuries. Front Neurol. 2019; 10: 875. DOI: https://doi.org/10.3389/fneur.2019.00875
15. Sun M.F., Shen Y.Q. Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s disease. Ageing Res Rev. 2018; 45: 53–61. DOI: https://doi.org/10.1016/j.arr.2018.04.004
16. Gazerani P. Probiotics for Parkinson’s disease. Int J Mol Sci. 2019; 20 (17): 4121. DOI: https://doi.org/10.3390/ijms20174121
17. Kouchaki E., Tamtaji O.R., Salami M., Bahmani F., Kakhaki R.D., Akbari E., et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017; 36 (5): 1245–9. DOI: https://doi.org/10.1016/j.clnu.2016.08.015
18. Tian P., Wang G., Zhao J., Zhang H., Chen W. Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis. J Nutr Biochem. 2019; 66: 43–51. DOI: https://doi.org/10.1016/j.jnutbio.2019.01.007
19. Duranti S., Ruiz L., Lugli G.A., Tames H., Milani C., Mancabelli L., et al. Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA. Sci Rep. 2020; 10 (1): 14112. DOI: https://doi.org/10.1038/s41598-020-70986-z
20. Yunes R.A., Poluektova E.U., Dyachkova M.S., Klimina K.M., Kovtun A.S., Averina O.V., et al. GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. Anaerobe. 2016; 42: 197–204. DOI: https://doi.org/10.1016/j.anaerobe.2016.10.011
21. Barrett E., Ross R.P., O’Toole P.W., Fitzgerald G.F., Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012; 113 (2): 411–7. DOI: https://doi.org/10.1111/j.1365-2672.2012.05344.x
22. Oleskin A.V., Shenderov B.A., Rogovsky V.S. Role of neurochemicals in the interaction between the microbiota and the immune and the nervous system of the host organism. Probiotics Antimicrob Proteins. 2017; 9 (3): 215–34. DOI: https://doi.org/10.1007/s12602-017-9262-1
23. Ferrer I., Vidal N. Neuropathology of cerebrovascular diseases. Handb Clin Neurol. 2017; 145: 79–114. DOI: https://doi.org/10.1016/B978-0-12-802395-2.00007-9
24. Rahaman P., Del Bigio M.R. Histology of brain trauma and hypoxia-ischemia. Acad Forensic Pathol. 2018; 8 (3): 539–54. DOI: https://doi.org/10.1177/1925362118797728
25. Buresh Ya., Bureshova O., H’yuston D.P. Methods and basic experiments for studying the brain and behavior. Moscow: Vysshaya shkola, 1991: 399 p. (in Russian)
26. Habriev R.U. Guidelines for experimental (preclinical) study of new pharmacological substances. Moscow: Meditsina, 2005: 832 p. (in Russian)
27. Farkhutdinov R.R., Likhovskikh V.A. Chemiluminescent methods for studying free radical oxidation in biology and medicine. Ufa, 1995: 87 p. (in Russian)
28. Gavrilov V.B., Gavrilova A.R., Mazhul’ L.M. Analysis of the procedures for estimation of lipid peroxidation products using thiobarbituric acid test. Voprosy meditsinskoy khimii [Problems of Medical Chemistry]. 1987; 33 (1): 118–22. (in Russian)
29. Korolyuk M.A., Ivanova L.I., Mayorova I.G., Tokarev V.E. Method for determining catalase activity. Laboratornoe delo [Laboratory Work]. 1988; (1): 16–9. (in Russian)
30. Surace M.J., Block M.L. Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci. 2012; 69 (14): 2409–27. DOI: https://doi.org/10.1007/s00018-012-1015-4
31. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007; 21 (1): 9–19. DOI: https://doi.org/10.1016/j.bbi.2006.08.009
32. van der Kleij H., O’Mahony C., Shanahan F., O’Mahony L., Bienenstock J. Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Regul Integr Comp Physiol. 2008; 295 (4): 1131–7. DOI: https://doi.org/10.1152/ajpregu.90434.2008
33. Quaresma M., Damasceno S., Monteiro C., Lima F., Mendes T., Lima M., et al. Probiotic mixture containing Lactobacillus spp. and Bifidobacterium spp. attenuates 5-fluorouracil-induced intestinal mucositis in mice. Nutr Cancer. 2020; 72 (8): 1355–65. DOI: https://doi.org/10.1080/01635581.2019.1675719
34. Yano J.M. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015; 161 (2): 264–76. DOI: https://doi.org/10.1016/j.cell.2015.02.047
35. Oleskin A.V., Shenderov B.A. Probiotics and psychobiotics: the role of microbial neurochemicals. Probiotics Antimicrob Proteins. 2019; 11 (4): 1071–85. DOI: https://doi.org/10.1007/s12602-019-09583-0
36. Guo Y., Xie J.P., Deng K., Li X., Yuan Y., Xuan Q., et al. Prophylactic effects of Bifidobacterium adolescentis on anxiety and depression-like phenotypes after chronic stress: a role of the gut microbiota-inflammation axis. Front Behav Neurosci. 2019; 13: 126. DOI: https://doi.org/10.3389/fnbeh.2019.00126
37. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008; 43 (2): 164–74. DOI: https://doi.org/10.1016/j.jpsychires.2008.03.009
38. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005; 4 (2): 141–94. DOI: https://doi.org/10.1016/j.arr.2005.03.003
39. Agus A., Planchais J., Sokol H. Gut Microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018; 23 (6): 716–24. DOI: https://doi.org/10.1016/j.chom.2018.05.003
40. Baj A., Moro E., Bistoletti M., Orlandi V., Crema F., Giaroni C. Glutamatergic signaling along the microbiota-gut-brain axis. Int J Mol Sci. 2019; 20 (6): 1482. DOI: https://doi.org/10.3390/ijms20061482
41. Du Y., Gao X.R., Peng L., Ge J.F. Crosstalk between the microbiota-gut-brain axis and depression. Heliyon. 2020; 6 (6): e04097. DOI: https://doi.org/10.1016/j.heliyon.2020.e04097
42. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011; 12 (8): 453–66. DOI: https://doi.org/10.1038/nrn3071
43. Andersson U., Tracey K.J. Reflex principles of immunological homeostasis. Annu Rev Immunol. 2012; 30: 313–35. DOI: https://doi.org/10.1146/annurev-immunol-020711-075015
44. Altavilla D., Guarini S., Bitto A., Mioni C., Giuliani D., Bigiani A., et al. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects against splanchic artery occlusion shock. Shock. 2006; 25 (5): 500–6. DOI: https://doi.org/10.1097/01.shk.0000209539.91553.82